SIMPLEX TRADING, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2022$487,000
+1523.3%
48,092
+1308.3%
0.00%
Q2 2022$30,000
-62.5%
3,415
-59.4%
0.00%
Q1 2022$80,000
-68.5%
8,401
-63.6%
0.00%
Q4 2021$254,000
+2016.7%
23,065
+2613.5%
0.00%
Q3 2021$12,000
+20.0%
850
+13.3%
0.00%
Q2 2021$10,000750
+4900.0%
0.00%
Q4 2020$0
-100.0%
15
-98.6%
0.00%
Q2 2020$23,000
-86.7%
1,103
-83.5%
0.00%
Q4 2019$173,000
+76.5%
6,689
+32.6%
0.00%
Q3 2019$98,000
+55.6%
5,043
+30.3%
0.00%
Q2 2019$63,0003,871
+64416.7%
0.00%
Q1 2019$0
-100.0%
6
-96.2%
0.00%
Q4 2018$4,000
+300.0%
157
+324.3%
0.00%
Q3 2018$1,000
-93.8%
37
-94.8%
0.00%
Q2 2018$16,000709
+2115.6%
0.00%
Q1 2018$0
-100.0%
32
-97.3%
0.00%
-100.0%
Q3 2017$40,000
-71.4%
1,177
-66.7%
0.00%
-66.7%
Q2 2017$140,000
+382.8%
3,538
+329.4%
0.01%
+200.0%
Q3 2016$29,000
+262.5%
824
+129.5%
0.00%
+100.0%
Q2 2016$8,000359
+11866.7%
0.00%
Q1 2016$030.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Link Fund Solutions Ltd 5,251,349$135,459,00069.86%
Chescapmanager LLC 949,006$24,570,0003.61%
Baupost Group 9,309,168$241,014,0002.66%
Rock Springs Capital Management LP 655,200$16,963,0000.54%
Rubric Capital Management LP 173,400$4,489,0000.51%
Newtyn Management, LLC 173,300$4,487,0000.41%
NJ State Employees Deferred Compensation Plan 38,142$988,0000.17%
King Wealth Management Group 22,500$583,0000.15%
Virtus ETF Advisers LLC 29,216$756,0000.12%
JACOBS LEVY EQUITY MANAGEMENT, INC 452,615$11,718,0000.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders